Hikma Pharmaceuticals Plc Block listing Interim Review (6090B)
October 03 2022 - 10:52AM
UK Regulatory
TIDMHIK
RNS Number : 6090B
Hikma Pharmaceuticals Plc
03 October 2022
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 3 October 2022
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
-------------------------------------------------------------
Period of return From: 1 April 2022 To: 30 September 2022
--------------------------- ----- -------------------------
Balance of unallotted securities under scheme(s) from SOP: 792,700 Ordinary Shares of 10 pence
previous return:
-------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been SOP: 0 Ordinary Shares of 10 pence
increased since the date of the last
return (if any increase has been applied for):
-------------------------------------------------------------
Less: Number of securities issued/allotted under SOP: 0 Ordinary Shares of 10 pence
scheme(s) during period (see LR3.5.7G):
-------------------------------------------------------------
Equals: Balance under scheme(s) not yet SOP: 792,700 Ordinary Shares of 10 pence
issued/allotted at end of period:
-------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 October 2022
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
---------------------------------------------------------------------
Period of return From: 1 April 2022 To: 30 September 2022
------------------------------- ------ ----------------------------
Balance of unallotted securities under LTIP: 57,502 Ordinary Shares of 10 pence
scheme(s) from previous return:
---------------------------------------------------------------------
Plus: The amount by which the block scheme(s) LTIP: 0 Ordinary Shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
---------------------------------------------------------------------
Less: Number of securities issued/allotted LTIP: 0 Ordinary Shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
---------------------------------------------------------------------
Equals: Balance under scheme(s) not yet LTIP: 57,502 Ordinary Shares of 10 pence
issued/allotted at end of period:
---------------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 October 2022
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")
--------------------------------------------------------------------------
Period of return From: 1 April 2022 To: 30 September 2022
--------------------------------- ------- ------------------------------
Balance of unallotted securities under 2009 MIP: 0 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------------
Plus: The amount by which the block 2009 MIP: 0 Ordinary Shares of 10 pence
scheme(s) has been increased since the
date of the last
return (if any increase has been applied
for):
--------------------------------------------------------------------------
Less: Number of securities 2009 MIP: 0 Ordinary Shares of 10 pence
issued/allotted under scheme(s) during
period (see LR3.5.7G):
--------------------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2009 MIP: 0 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 October 2022
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP")
--------------------------------------------------------------------------
Period of return From: 1 April 2022 To: 30 September 2022
--------------------------------- ------- ------------------------------
Balance of unallotted securities under 2018 MIP: 428,200 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------------
Plus: The amount by which the block 2018 MIP: 0 Ordinary Shares of 10 pence
scheme(s) has been increased since the
date of the last
return (if any increase has been applied
for):
--------------------------------------------------------------------------
Less: Number of securities 2018 MIP: 14,088 Ordinary Shares of 10 pence
issued/allotted under scheme(s) during
period (see LR3.5.7G):
--------------------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2018 MIP: 414,112 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 October 2022
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
--------------------------------------------------------------------
Period of return From: 1 April 2022 To: 30 September 2022
------------------------------ ------ ----------------------------
Balance of unallotted securities under EIP: 458,189 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------
Plus: The amount by which the block scheme(s) EIP: 0 Ordinary Shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------------
Less: Number of securities issued/allotted EIP: 103,227 Ordinary Shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
--------------------------------------------------------------------
Equals: Balance under scheme(s) not yet EIP: 354,962 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRUPGBCUUPPGCW
(END) Dow Jones Newswires
October 03, 2022 10:52 ET (14:52 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
